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Abstract
Background: Researchers have long recognized that stigma is a global, multi-level phenomenon requiring intervention
approaches that target multiple levels including individual, interpersonal, community, and structural levels. While existing
interventions have produced modest reductions in stigma, their full reach and impact remain limited by a
nearly exclusive focus targeting only one level of analysis.
Methods: We conducted the first systematic review of original research on multi-level stigma-reduction interventions.
We used the following eligibility criteria for inclusion: (1) peer-reviewed, (2) contained original research, (3) published
prior to initiation of search on November 30, 2017, (4) evaluated interventions that operated on more than one level,
and (5) examined stigma as an outcome. We stratified and analyzed articles by several domains, including whether the
research was conducted in a low-, middle-, or high-income country.
Results: Twenty-four articles met the inclusion criteria. The articles included a range of countries (low, middle, and high
income), stigmatized conditions/populations (e.g., HIV, mental health, leprosy), intervention targets (e.g., people living
with a stigmatized condition, health care workers, family, and community members), and stigma reduction strategies
(e.g., contact, social marketing, counseling, faith, problem solving), with most using education-based approaches. A
total of 12 (50%) articles examined community-level interventions alongside interpersonal and/or intrapersonal levels,
but only 1 (4%) combined a structural-level intervention with another level. Of the 24 studies, only 6 (25%)
were randomized controlled trials. While most studies (17 of 24) reported statistically significant declines in
at least one measure of stigma, fewer than half reported measures of practical significance (i.e., effect size);
those that were reported varied widely in magnitude and were typically in the small-to-moderate range.
Conclusions: While there has been progress over the past decade in the development and evaluation of
multi-level stigma interventions, much work remains to strengthen and expand this approach. We highlight
several opportunities for new research and program development.
Keywords: Stigma, Multi-level interventions, Low- and middle-income countries
Background
Stigma can aggravate disease processes and add numer-
ous socioeconomic, psychosocial, and health burdens on
people who hold marginalized identities or statuses, in-
cluding reduced educational attainment, exposure to
psychosocial stressors, and challenges in accessing
healthcare [1]. Behavioral scientists have studied the
severe negative consequences of stigma for individuals
coping with various health conditions and have learned
that stigma can deter individuals from optimally en-
gaging in treatment for their condition, which has ser-
ious impacts on morbidity and mortality [2]. Strikingly,
when disease morbidity and mortality are low but the
condition is highly stigmatized, the burden of stigma
may exceed the burden of the disease in its impact on
social, emotional, and work functioning, thus negatively
affecting the overall quality of life [3]. Researchers have
long recognized that stigma operates on intrapersonal,
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interpersonal, organizational, and structural levels, and
as such, stigma is conceptualized as an inherently
multi-level phenomenon [1]. The multi-level nature of
stigma renders the development of stigma interventions
particularly challenging, in part because addressing mul-
tiple levels through research is more complex, requires
more resources, and may be more burdensome to partic-
ipants than single-level interventions. However, for re-
search teams willing to take on the task of addressing
multiple levels, the impacts on stigma reduction efforts
can be farther reaching, more synergistic, and more hol-
istic than single-level interventions [4].
Two previous papers have reviewed the literature
on stigma reduction interventions. In Heijnders and
Van Der Meij’s 2006 review [5], consistent with the
multi-level approach to stigma [1], the authors identi-
fied five levels of examination and mapped strategies
and target populations directly onto each level. First,
at the intrapersonal level, the focus of interventions is
on characteristics of the individuals living with a stig-
matized condition, and strategies involve self-help,
counseling, and treatment. Second, at the interper-
sonal level, the intervention is focused on the en-
hancement of care and support in the stigmatized
persons’ local environment. Third, at the community
level, the focus is on reducing stigmatizing attitudes
and behaviors in (non-stigmatized) community groups
using strategies such as education, contact, and advo-
cacy. Heijnders and Van Der Meij define contact as
any interactions between the public and the affected
person for the purpose of reducing stigma [5]. Fourth,
at the organizational/institutional level, interventions
focus on reducing stigma in an organization or insti-
tution, and strategies include training programs and
institutional policies. Fifth, at the governmental/struc-
tural level, interventions focus on establishing and
enforcing legal, policy, and rights-based structures.
In 2014, Cook and colleagues [6] conducted a narra-
tive review that similarly considered multiple levels in
which stigma interventions can operate as part of an
ecological system [7], but focused on only three levels:
intrapersonal, interpersonal, and structural. Cook et al.’s
definitions of these levels differed slightly from those of
Heijnders and Van Der Meij’s and were more flexible, in
that one strategy, such as education, could operate on
multiple levels. The authors’ primary purpose was to de-
scribe how each strategy operates on multiple levels,
while targeting both stigmatized and non-stigmatized
populations.
Although neither review was systematic, both chal-
lenged investigators to build and evaluate multi-level
stigma reduction interventions. In Heijnders and Van
Der Meij’s review [5], while all of the strategies
reviewed had the potential to operate on multiple
levels, the authors reviewed studies that evaluated
stigma reduction strategies at a single level of analysis.
In their conclusion, they called for researchers to com-
bine multiple strategies to target multiple levels. Cook
and colleagues [6] conducted an updated narrative re-
view of stigma interventions and analyzed these studies
for cascading impacts across multiple levels. The au-
thors determined that studies examining cascading ef-
fects across levels were rare, concluding that stigma
reduction interventions that examine effects across
levels were urgently needed. While these two prior re-
views pointed out important lacuna in the literature on
stigma interventions, our study addresses another
knowledge gap by conducting the first systematic re-
view of multi-level stigma interventions. We describe
the country of origin of research studies, depict the de-
sign and participants of each multi-level stigma inter-
vention, discuss the strategies and outcomes used by
these interventions, and highlight opportunities for new
research and program development.
Methods
We conducted this review in accordance with the
Preferred Reporting Items for Systematic Reviews
(PRISMA) guidelines [8]. We included studies that fo-
cused on stigma reduction interventions operating on
multiple levels, both within and outside of the USA. The
overall purpose of our review was descriptive, rather
than evaluative. Thus, for each study, we provide a basic
indication of effectiveness in reducing stigma, but a de-
tailed evaluation of study effectiveness was beyond the
scope of this review.
We used Heijnders and Van Der Meij’s categories
for the levels of the ecological system (i.e., intraper-
sonal, interpersonal, community, organizational/insti-
tutional, governmental/structural) [5]. However, we
expanded our organization of these predefined strat-
egies (e.g., education, contact) such that they could
map onto multiple levels, which Heijnders and Van
Der Meij did not do in their analysis. For example, if
one target of an intervention was to improve attitudes
held, whether by the stigmatized or the non-stigma-
tized, we categorized this focus at the intrapersonal
level. If an intervention’s target was to improve inter-
actions between people with stigmatized conditions
and other stakeholders (e.g., caregivers, healthcare
workers), we categorized this focus at the interper-
sonal level. If the (non-stigmatized) public was tar-
geted, we identified the community level as the focus.
If an organization was targeted, we identified the
organizational/institutional level as the focus. If a pol-
icy or administrative structure was targeted, we identi-
fied governmental/structural level as the focus.
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Search terms
For our systematic review, we input search terms into six
electronic database sources (PubMed, Embase, CINAHL,
Global Health, Scopus, and PsychINFO). We looked for
all papers with the term “stigma” plus at least one of the
following terms: “intervention,” “program,” “programme,”
or “policy” in either the title or abstract. We used the
Covidence database [9] to extract and organize informa-
tion from articles. Because of our focus on health-related
stigmas, we used primarily health-based databases in our
search.
Inclusion criteria
We used the following eligibility criteria for inclusion:
(1) peer-reviewed, (2) contained original research, (3)
published prior to initiation of search on November 30,
2017, (4) evaluated interventions that operate on more
than one level, as defined above, and (5) examined
stigma as an outcome.
Exclusion criteria
We excluded protocol papers, papers published in lan-
guages other than English, abstracts without full texts
available, non-peer reviewed articles, and solely qualita-
tive studies.
Data extraction
After identifying a list of all relevant records and remov-
ing duplicates, 10,621 titles remained for title, abstract,
and full-text screening. The abstract/title review and
subsequent full-text review of the selected studies were
conducted independently by two investigators (AE and
MN), who had approximately 99% agreement, disagree-
ing on only 39 of 10,621 articles. Discrepancies were re-
solved over discussions with two additional investigators
(DR and VG). The investigators retained 138 articles
after abstract screening and 24 articles after full-text
screening based on the inclusion/exclusion criteria
above. One hundred and fourteen articles were excluded
during full-text screening because we found the articles
met exclusion criteria only after reviewing the full text.
This process is depicted in Fig. 1.
Data analysis
We used content analysis [10] to organize the selected
qualifying studies. DR and SF independently coded each
article. We read through each article and systematically
created and collapsed categories. When SF and DR en-
countered discrepancies, the codes were discussed and
adjusted by consensus and the levels, as presented above.
The themes identified from the articles included the fol-
lowing: condition/population studied (e.g., HIV, mental
health, substance use, leprosy, diabetes, epilepsy, or-
phaned and vulnerable children), intervention targets
(e.g., people living with a condition, health care workers,
caregivers/family members, community members), level
of intervention targeted, country that served as the setting
for the study, and stigma reduction strategies used in the
interventions (e.g., education, contact, social marketing,
counseling, faith, problem solving). We also coded articles
for information on the intensity of the strategies used
(e.g., duration, number of sessions) and whether the
studies used validated stigma measures. We examined ef-
fectiveness using a simple, parsimonious approach, cat-
egorizing findings in terms of statistical significance (at
least 1 measure of stigma used showed statistically signifi-
cant reduction) or statistical non-significance (no statis-
tical significance found or no inferential statistics used).
We provided confidence intervals when given in the arti-
cles, and effect sizes if given or if enough information was
given to calculate effect sizes in the articles.
Results
Overall, six of the 24 studies were randomized controlled
trials (two used individual randomization [11, 12] and four
used cluster randomization [13–16]) (Table 1). Eighteen
studies did not randomize or use a control group and thus
were not considered randomized controlled trials (RCTs).
Most studies reported on pilot trials of interventions. Of
the studies reviewed that did use RCT designs, four used
cluster randomization. All studies used convenience sam-
ples rather than population-based sampling.
We found approximately equal numbers of studies ori-
ginating from low- and middle-income country (LMIC)
and high-income country (HIC) settings, with 13 studies
conducted in HIC and 11 studies conducted in LMIC.
Five studies were based in the US, three in the UK, two
in Canada, two in Indonesia, two in South Africa, and
one study spanned five African countries (Lesotho,
Malawi, South Africa, Swaziland, and Tanzania). One
study was conducted in each of the following countries:
Kenya, Zambia, China, India, Vietnam, Israel, Haiti,
Australia, and Japan.
Twelve articles examined stigma associated with men-
tal illness, six HIV, two leprosy, one Moebius syndrome,
and one each of epilepsy, orphans and vulnerable chil-
dren, and substance use. Eighteen articles described
studies targeting stigmatized participants, 12 included
participants who were community members (e.g., stu-
dents, police), six articles included healthcare workers as
participants, eight articles addressed stigma among care-
givers/family members, and two articles examined
stigma among youth at risk for HIV. Of the articles tar-
geting stigmatized populations, six studies targeted both
stigmatized and community populations, eight studies
targeted both stigmatized and caregiver populations, and
six studies targeted both stigmatized and healthcare
worker populations.
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Five of the six articles examining HIV-related stigma
originated from LMICs. Conversely, articles examining
mental illness-related stigma predominantly came from a
HIC (e.g., UK, US, Canada), with only one out of 12 arti-
cles from a LMIC (India). Five studies were published
prior to 2010, whereas 19 were published between 2010
and 2017. Five of the six studies of HIV-related stigma
were published after 2010, and nine of 12 studies of men-
tal health-related stigma were published in 2010 or after.
The most common levels examined together were
intrapersonal and interpersonal, with 15 articles includ-
ing these two levels together. Of the 24 articles, four ex-
amined the community level alongside both the
intrapersonal and interpersonal levels. Three articles ex-
amined intrapersonal and community levels together,
and another three examined interpersonal and commu-
nity levels together. Thus, a total of 10 articles examined
community levels alongside either interpersonal, intra-
personal, or both levels. Only one article examined the
institutional level (along with intrapersonal), and no arti-
cles targeted the structural level. Figure 2 depicts these
findings, separated by LMIC and HIC study location.
The most common stigma reduction strategy studied
was education, with 16 studies using this strategy. Ten
studies examined contact, five counseling or coping
skills acquisition, three social support, three drama, and
two problem solving. Individual studies also examined
communication skills, voluntary counseling and testing,
psychiatric treatment, and outdoor adventure as stigma
reduction techniques. Of the 12 articles that examined
the community level alongside at least one other level,
six used contact as a primary strategy. Eight studies used
education and contact strategies together, and six of
these eight studies originated from HIC.
Seven of the 24 studies examined one stigma reduction
strategy across more than one level. For example, Patalay
and colleagues [17] trained university medical students in
the UK to lead workshops with secondary school students
on mental health conditions and services (educational
strategy). Investigators measured medical students’ levels
of stigma and impact on the interpersonal level to exam-
ine the workshop leadership’s potential impact on medical
students’ future practice behaviors. The researchers also
measured attitudes towards mental illness of the recipients
of the intervention, (the secondary school students),
thereby using the same educational strategy and then
assessing community-level stigma. Of note, one study
used an educational strategy with specialized areas of con-
tent: Brown and colleagues [18] had nursing students de-
liver a stigma reduction program in the US to community
members by providing information on mental health is-
sues as well as on a faith-based framework for dealing
with mental health issues. In other words, this interven-
tion provided education on a condition as well as educa-
tion on using faith to cope with the condition (two
educational strategies), without using faith-based counsel-
ing techniques as the intervention itself.
The majority (16 of 24) of studies reviewed used
stigma scales that were validated and used in multiple
countries. The remaining eight studies used scales that
Fig. 1 Flow of article inclusion and exclusion from review
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were adapted from validated scales, used in a neighbor-
ing country, or validated by the study team for use in
the country where the study had taken place. Beyond
use of validated and adapted measures, the articles pro-
vided little information on how well the instruments
performed across cultures and contexts.
In terms of effectiveness, 17 studies reported that their
intervention reduced stigma scores (p < 0.05) on at least
one measure of stigma and seven studies reported
non-significant results. Of these seven studies that found
non-significance, five were conducted in high-income
countries and two were conducted in middle-income
countries (China and South Africa). Only two of the 24
articles provided information on confidence intervals. In
terms of practical significance, only 11 out of the 24
studies provided information to calculate effect sizes or
the effect sizes themselves. Cohen’s d values that were
reported ranged from 0.4 to 2.51, Eta squared and
R-squared values ranged from 0.02 to 0.32, indicating
small-to-moderate effects across studies.
Discussion
We set out to review intervention studies that
targeted multiple levels of stigma reduction and
identified 24 studies. Notably, the majority of studies
identified and reviewed were published after 2010,
demonstrating an increasing urgency and movement
in the research community towards developing and
validating stigma reduction interventions. Articles
that originated from HICs tended to examine mental
illness-related stigma, whereas those from LMICs
tended toward the examination of HIV-related stigma.
This may be due to availability of funds, as global
health spending in LMICs has decreased over time ex-
cept for HIV-related work [19].
Most investigators used validated or adapted mea-
sures of stigma in their studies, but provided little in-
formation on how well the measures performed in
diverse settings. Contextual psychometric information
and sensitivity/specificity of measures are useful pieces
of information to determine accurate interpretation of
intervention effectiveness. This is particularly relevant
for studies that used adapted measures or measures val-
idated in languages or contexts that differed from
where the studies were conducted. More detailed exam-
ination of measures used to evaluate intervention ef-
fectiveness will be an important direction for future
research on multi-level interventions.
Fig. 2 Levels examined together, separated by high- and low/middle-income country
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Similarly, we found relatively few studies that used ran-
domized controlled trial (RCT) designs. The lack of RCT
designs may be due to the challenges of conducting RCTs
across multiple levels. Investigators in future studies of
multi-level stigma interventions may consider use of
non-traditional hybrid trial designs, quasi-experimental
designs, or other types of pragmatic designs used in com-
plex real-world settings. Similarly, we also noted that just
under half of the reviewed articles provided effect sizes,
and those that were reported varied widely in magnitude.
Adding rigor to these designs may help to narrow infor-
mation on the potential benefits of interventions that op-
erate on multiple levels.
The intrapersonal and interpersonal levels were most
often targeted by the multi-level stigma interventions
studied, which may be due to several factors. The broader
stigma literature has focused almost exclusively on these
two levels of analysis [1]; thus, multi-level interventions
have a larger evidence base from which to draw at these
levels. Relatedly, research has accumulated a wealth of
stigma measures at the individual/interpersonal levels of
analysis. In contrast, until recently, fewer measures of
stigma existed at community, organizational, and struc-
tural levels, which likely hindered the assessment of
multi-level stigma interventions that incorporated
communities and social structures [20]. This focus on the
individual/interpersonal levels in multi-level stigma inter-
ventions may also be due to convenience—intervention
studies are often easier to implement in clinical settings
where people with health-related stigmatizing conditions
seek care and where their family members (who are
needed for research at the interpersonal level) are more
easily identified and assessed. More research is needed to
incorporate community-, organizational-, and structural-
level influences into multi-level stigma interventions.
Approximately half the studies reviewed examined
community-level stigma reduction, with intrapersonal
and/or interpersonal levels. Studies that targeted com-
munity levels of stigma predominantly used methods of
interaction, or contact, across populations studied,
examining the impact of exchanging information and
making use of bi-directional learning and including
people living with stigmatized conditions in the process
(e.g., teaching, drama). In addition, these studies tended
to incorporate exchanges of support, particularly when
family members and health care workers were involved.
Despite accumulating research indicating that struc-
tural forms of stigma contribute to adverse health out-
comes among members of stigmatized groups [21, 22],
only one study combined an institutional-level approach,
and no studies combined the structural-level approach,
alongside another level. Researchers may consider insti-
tutional- and structural-level interventions challenging,
since they require time and financial resources to
examine stigma in large samples. Despite these chal-
lenges, single-level studies are beginning to emerge that
examine stigma reduction as a result of policy changes
at the structural level [23]. Thus, one important direc-
tion for future development of multi-level interventions
is greater attention to, and incorporation of, policy-level
interventions to address stigma at the institutional and
structural levels.
With respect to stigma-reduction strategies used by
these multi-level stigma interventions, most focused on
education, either alone or in combination with other strat-
egies, such as contact. Corrigan and colleagues found over
years of research that stand-alone educational programs
can lead to stereotype suppression, in which members of
the public suppress—rather than reject—stereotyped be-
liefs upon learning that such beliefs are socially undesir-
able [24, 25]. Thus, educational programs alone are often
ineffective in reducing stigmatizing attitudes in members
of the public, and the little resulting stigma reduction that
occurs may be short-lived and superficial [26]. Future re-
search on multi-level stigma interventions is therefore
needed to explore a wider range of stigma-reduction strat-
egies and to utilize evidence-based strategies that prior re-
search has shown to be effective in reducing stigma.
This review has several limitations. First, although we
introduced independent secondary article reviewers and
coders, our process of article selection, non-inclusion of
gray literature, inclusion of studies reported in English
only, and content analysis may have introduced selection
biases that restrict the generalizability of our findings to
all multi-level stigma interventions. Second, the scope of
our study did not include detailed comments regarding
a methodological appraisal of studies and we included
limited information on intervention effectiveness. The
lack of rigor in these studies may have led to sampling
bias and non-generalizable conclusions. Thus, additional
research will need to be done before recommendations
on effectiveness can be made.
Conclusions
Stigma is inherently a cross-sectoral phenomenon [1]
and thus efforts to reduce stigma and its pernicious ef-
fects require a multi-level approach. Despite progress
over the past decade in the development of multi-level
stigma interventions, much work remains to strengthen
and broaden this approach. In Table 2, we highlight sev-
eral opportunities for new research and program devel-
opment in multi-level stigma interventions, organized
around several key domains (e.g., measurement, mecha-
nisms of change, implementation). This list is not ex-
haustive, but rather is meant to underscore some of the
most important areas of inquiry that are needed to ad-
vance the knowledge base in this incipient field. For in-
stance, multi-level stigma interventions may not always
Rao et al. BMC Medicine           (2019) 17:41 Page 9 of 11
be appropriate; future research is therefore needed to
systematically compare the efficacy of single-level vs.
multi-level stigma interventions in order to determine
the conditions under which multi-level stigma interven-
tions may be preferable to single-level interventions. Fu-
ture research is also needed to evaluate how changes at
one level of stigma (e.g., intrapersonal) impact other
levels of stigma (e.g., community) in order to guide the
development of more effective multi-level interven-
tions, to identify mechanisms of change in multi-level
stigma interventions, and to explore the barriers and
facilitators to the dissemination of multi-level stigma
interventions across diverse contexts. Only after an-
swering these questions will it be possible to fully
evaluate whether multi-level stigma interventions are
effective in addressing the predicament of stigma in
the lives of the stigmatized.
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